Effect of strength training versus raloxifene on bone weight, blood glucose, lipid and antioxidant profile in ovariectomized rats

Santos, Marcos Antônio Pereira dos; Carvalho e Martins, Maria do Carmo de; Silva, Raquel Suelen Brito da; Lopes, Carolina Farias de Arruda; Silva, Alexandre Sérgio.
Acta sci., Biol. sci ; 45: e59835, 2023. tab, graf
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1419132

Documentos relacionados

  1. The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
  2. Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects.
  3. Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.
  4. Efficacy of combined medication of risedronate sodium and selective estrogen receptor modulator on the postmenopausal osteoporosis.
  5. Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
  6. Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women.
  7. Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders.
  8. Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.
  9. Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.
  10. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.